Lancet Global Health

Papers
(The H4-Index of Lancet Global Health is 71. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Global health research funding applications: brain drain under another name?891
Bringing home manufacturing of medical products359
Queering global health: a feminist and lesbian, gay, and bisexual perspective – Authors' reply316
Influenza vaccination in failing hearts314
Periconceptional diet and the risk of gestational diabetes in south Indian women: findings from the BAngalore Nutrition Gestational diabetes LiFEstyle Study (BANGLES)310
Preventing pellagra during isoniazid preventive treatment307
Correction to Lancet Glob Health 2024; published online Sept 23. https://doi.org/10.1016/S2214-109X(24)00320-6284
Correction to Lancet Glob Health 2021; 9: e1679–87255
The cause of nodding syndrome remains unknown245
Mpox vaccination strategies in DR Congo237
Investing in late-stage clinical trials and manufacturing of product candidates for five major infectious diseases: a modelling study of the benefits and costs of investment in three middle-income cou235
Racism and health: the need for urgent action217
Prenatal exposure to HIV pre-exposure prophylaxis and birth, growth, and social–emotional developmental outcomes throughout early childhood in Kenya: a prospective cohort study205
Is now the time for revisiting supplements for pregnant women?195
Automated oxygen control for preterm infants receiving continuous positive airway pressure in southwest Nigeria: an open-label, randomised, crossover trial176
Assessing the prevalence and impact of preserved ratio impaired spirometry in low-income and middle-income countries: a post-hoc cross-sectional analysis175
Financial incentives for reduced alcohol use and increased isoniazid adherence during tuberculosis preventive therapy among people with HIV in Uganda: an open-label, factorial randomised controlled tr161
Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical m159
The future of the International Health Regulations157
Enhancing global cancer care for sexual and gender minority populations: regional perspectives and global implications154
Outcomes of rheumatic fever in Uganda: a prospective cohort study152
Comparison of maternal and neonatal outcomes of COVID-19 before and after SARS-CoV-2 omicron emergence in maternity facilities in Malawi (MATSurvey): data from a national maternal surveillance platfor151
Resolving the CD4-testing crisis to help end AIDS-related deaths150
C-reactive protein: another addition to our armamentarium against tuberculosis?148
Indonesia's first nationwide health screening programme144
Intravenous versus oral iron for anaemia among pregnant women in Nigeria (IVON): an open-label, randomised controlled trial143
Challenges in operationalising clinical trials in India during the COVID-19 pandemic137
Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study136
Global and regional sepsis and infectious syndrome mortality in 2019: a systematic analysis134
The drug drought in maternal health: an ongoing predicament134
The health status of Indonesia's provinces: the double burden of diseases and inequality gap128
The state of health in Pakistan and its provinces and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019127
Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial127
Performance of standardised colposcopy to detect cervical precancer and cancer for triage of women testing positive for human papillomavirus: results from the ESTAMPA multicentric screening study125
Effectiveness and safety of fexinidazole for gambiense human African trypanosomiasis and exploration of adherence in outpatients: a phase 3b, prospective, open-label, non-randomised, cohort study122
Mortality in patients admitted to hospital with heart failure in China: a nationwide Cardiovascular Association Database-Heart Failure Centre Registry cohort study122
The cost of inaction on physical inactivity to public health-care systems: a population-attributable fraction analysis122
Global patterns and trends in Kaposi sarcoma incidence: a population-based study117
Human papillomavirus vaccine effect against human papillomavirus infection in Rwanda: evidence from repeated cross-sectional cervical-cell-based surveys112
Implementation of the 7-1-7 target for detection, notification, and response to public health threats in five countries: a retrospective, observational study111
Patient-level and system-level determinants of stroke fatality across 16 large hospitals in Ghana and Nigeria: a prospective cohort study102
WHO model list of essential in vitro diagnostics: strengthening diagnostics capacity to transform health care for all101
Addressing the complex needs of people with severe mental health disorders in low-resource settings99
Locally validated biomarker cutoffs should inform micronutrient deficiency burdens – Authors' reply99
Commitment and innovation on the road to people-centred PHC financing97
Mpox: evidence for strengthening and sustaining global surveillance97
Achieving sensible targets for a diabetes care cascade in LMICs93
Pregnancy in people who have survived Ebola virus disease92
From child institutions to family reunification: challenges and opportunities in building family-centred care89
Lessons for future implementation of the E-MOTIVE bundle88
Payment in arrears: a global health inequity that must be corrected87
Addressing the social inequities of vaccination: an imperative to close the gap87
Child, maternal, and adult mortality in Sierra Leone: nationally representative mortality survey 2018–2086
A call for an Africa-centric health research ethics framework: a way forward for shaping global health research84
Introduction and rollout of malaria vaccines in Cameroon and Burkina Faso: early lessons learned83
Improving access to liposomal amphotericin B worldwide83
Mathematical modelling to accurately quantify the benefits of pneumococcal conjugate vaccine82
Impact of excluded studies on medical male circumcision and HIV risk compensation82
Experiences of an Israeli hospital in the management of repatriated civilian hostages81
Bridging the gap between science and policy in global health governance79
Using verbal autopsy to enhance mortality surveillance78
Correction to Lancet Glob Health 2022; 10: e1443–5277
Correction to Lancet Glob Health 2023; 11: e1978–8575
Complementary medicine as a risk factor for catastrophic expenditures in people with cancer75
How to DREAMM and end HIV-related deaths74
Staying focused on protecting young people from the harms of tobacco smoke74
Uncertainty in key population size estimates in sub-Saharan Africa74
Highlighting the need for investment and innovation in ART retention interventions74
Infertility—why the silence?73
The social determinants of tuberculosis in the Philippines72
Pregnancy, pregnancy outcomes, and infant growth and development after recovery from Ebola virus disease in Liberia: an observational cohort study72
Cholera rapid diagnostic tests recycled for PCR confirmation71
0.23019194602966